Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection.
Lee
Jooyun
J
Patel
Gopi
G
Huprikar
Shirish
S
Calfee
David P
DP
Jenkins
Stephen G
SG
D001202:Ascitic Fluid / Q000382:microbiology; D001769:Blood / Q000382:microbiology; D015780:Carbapenems / Q000494:pharmacology; D002555:Cerebrospinal Fluid / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy* / Q000382:microbiology; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D011112:Polymyxin B / Q000494:pharmacology / Q000627:therapeutic use*; D014481:United States
D015780:Carbapenems; D011112:Polymyxin B